BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31602468)

  • 21. A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
    Kamigaichi A; Hamada A; Tsuboi M; Yoshimura K; Okamoto I; Yamamoto N; Tsutani Y
    Clin Lung Cancer; 2024 Jun; 25(4):384-388.e1. PubMed ID: 38360496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
    Samson P; Patel A; Garrett T; Crabtree T; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1906-12; discussion 1913. PubMed ID: 25890663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively.
    Hu J; Chen Y; Zhu X; Ma Q; Zhang J; Jiang G; Zhang P
    BMC Cancer; 2021 Apr; 21(1):445. PubMed ID: 33888088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjacent lobe invasion of T2 tumor in non-small cell lung cancer has T3 disease-like survival fissure invasion: T2 or T3?
    Ucvet A; Yazgan S; Agaoglu Sanli B; Yamansavci Sirzai E
    Updates Surg; 2023 Oct; 75(7):2017-2025. PubMed ID: 37561317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis.
    Wu LL; Lai JJ; Liu X; Huang YY; Lin P; Long H; Zhang LJ; Ma GW
    World J Surg Oncol; 2020 Dec; 18(1):322. PubMed ID: 33287841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life after lung cancer surgery: sublobar resection versus lobectomy.
    Jiang S; Wang B; Zhang M; Liu Z; Xiao Z; Gong J; Wang X; Zhang Z; Zhang Z
    BMC Surg; 2023 Nov; 23(1):353. PubMed ID: 37980480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublobar resection reduces the risk of postoperative cognitive dysfunction compared with lobectomy.
    Zang N; Shen W; Li S; Chen L; Ai Q; Huang W; Lan L; Liu J; Wang W; Cui F; Huang J; Shao W; Huang X; Xu P; He J
    Eur J Cardiothorac Surg; 2023 Nov; 64(5):. PubMed ID: 37713465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
    Udelsman BV; Canavan ME; Zhan PL; Ely S; Park HS; Boffa DJ; Mase VJ
    J Thorac Cardiovasc Surg; 2024 Mar; 167(3):822-833.e7. PubMed ID: 37500052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial.
    Potter AL; Senthil P; Keshwani A; McCleery S; Haridas C; Kumar A; Mathey-Andrews C; Martin LW; Yang CJ
    Ann Thorac Surg; 2024 Apr; 117(4):734-742. PubMed ID: 38216080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes after sublobar resection versus lobectomy in non-small cell carcinoma in situ.
    Perez Holguin RA; Olecki EJ; Wong WG; Stahl KA; Go PH; Taylor MD; Reed MF; Shen C
    J Thorac Cardiovasc Surg; 2023 Mar; 165(3):853-861.e3. PubMed ID: 35760619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-reported dyspnoea and shortness of breathing deterioration in long-term survivors after segmentectomy or lobectomy for early-stage lung cancer.
    Brunelli A; Tariq J; Mittal A; Lodhia J; Milton R; Nardini M; Papagiannopoulos K; Tcherveniakov P; Teh E; Chaudhuri N
    Eur J Cardiothorac Surg; 2024 May; 65(5):. PubMed ID: 38748996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary: Lobectomy, segmentectomy, or wedge resection for stage IA lung cancer: Several choices, many questions.
    Rusch VW
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):348-349. PubMed ID: 37527725
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and efficacy of delayed completion lobectomy following wedge resection
    Wu Y; Jin K; Qin L; Li Z; Xu X; Dai J; Liu X; Xu X; Zhou X; Jiang G
    J Thorac Dis; 2024 Apr; 16(4):2379-2393. PubMed ID: 38738238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intentional wedge resection versus segmentectomy for ≤2 cm Ground-Glass-Opacity-Dominant Non-Small cell lung cancer: a Real-World study using inverse probability of treatment weighting.
    Liu C; Yang Z; Li Y; Guo C; Xia L; Zhang W; Xiao C; Mei J; Liao H; Zhu Y; Lin F; Ma L; Pu Q; Liu L
    Int J Surg; 2024 Mar; ():. PubMed ID: 38518080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resection of the Primary Tumor and Survival in Patients with Single-Site Synchronous Oligometastatic Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Database.
    Rodriguez-Quintero JH; Jindani R; Kamel MK; Zhu R; Vimolratana M; Chudgar NP; Stiles BM
    J Am Coll Surg; 2024 Jun; 238(6):1122-1136. PubMed ID: 38334285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobectomy versus proton therapy for stage I non-small cell lung cancer.
    Sakane T; Nakajima K; Iwata H; Nakano T; Hagui E; Oguri M; Nomura K; Hattori Y; Ogino H; Haneda H
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1490-1501.e2. PubMed ID: 37625619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Stage I Non-Small-Cell Lung Cancer Treatments for Patients Living With HIV: A Simulation Study.
    Sigel K; Silverberg MJ; Crothers K; Park L; Lishchenko I; Han X; Leyden W; Kale M; Stone K; Sigel C; Wisnivesky J; Kong CY
    Clin Lung Cancer; 2023 Nov; 24(7):e259-e267.e8. PubMed ID: 37407294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National trends in the quality of segmentectomy for lung cancer.
    Logan CD; Jacobs RC; Feinglass J; Lung K; Kim S; Bharat A; Odell DD
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):351-363.e20. PubMed ID: 36088143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance).
    Altorki N; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Stinchcombe TE
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):338-347.e1. PubMed ID: 37473998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Utility of a CT-based AI Prognostic Model for Segmentectomy in Non-Small Cell Lung Cancer.
    Na KJ; Kim YT; Goo JM; Kim H
    Radiology; 2024 Apr; 311(1):e231793. PubMed ID: 38625008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.